CWA Asset Management Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.8M Buy
97,695
+841
+0.9% +$196K 0.76% 23
2026
Q1
$23.7M Sell
96,854
-887
-0.9% -$207K 0.8% 25
2025
Q4
$20.2M Sell
97,741
-2,203
-2% -$436K 0.73% 25
2025
Q3
$18.5M Sell
99,944
-21,081
-17% -$3.61M 0.69% 29
2025
Q2
$18.5M Sell
121,025
-2,527
-2% -$388K 0.78% 25
2025
Q1
$20.5M Buy
123,552
+3,074
+3% +$481K 0.98% 21
2024
Q4
$17.4M Sell
120,478
-14,827
-11% -$2.3M 0.88% 23
2024
Q3
$21.9M Buy
+135,305
New +$21.6M 1.17% 15
2024
Q1
$17.1M Sell
107,785
-67,551
-39% -$10.8M 1.04% 19
2023
Q4
$27.5M Sell
175,336
-6,720
-4% -$1.03M 1.88% 7
2023
Q3
$28.4M Sell
182,056
-1,485
-0.8% -$245K 2.09% 6
2023
Q2
$30.4M Buy
183,541
+3,774
+2% +$609K 2.09% 9
2023
Q1
$27.9M Sell
179,767
-2,520
-1% -$407K 2.07% 9
2022
Q4
$32.2M Sell
182,287
-499
-0.3% -$86.2K 2.61% 6
2022
Q3
$29.9M Buy
182,786
+3,373
+2% +$571K 2.88% 8
2022
Q2
$31.8M Buy
179,413
+1,462
+0.8% +$260K 2.98% 7
2022
Q1
$31.5M Sell
177,951
-379
-0.2% -$64.5K 2.41% 9
2021
Q4
$30.5M Buy
178,330
+2,757
+2% +$451K 2.26% 9
2021
Q3
$28.4M Buy
175,573
+7,557
+4% +$1.29M 2.25% 7
2021
Q2
$27.9M Buy
168,016
+5,952
+4% +$985K 2.26% 8
2021
Q1
$26.6M Buy
162,064
+11,335
+8% +$1.83M 2.43% 8
2020
Q4
$23.7M Buy
150,729
+20,467
+16% +$3.02M 2.49% 6
2020
Q3
$19.4M Buy
130,262
+18,913
+17% +$2.8M 2.59% 7
2020
Q2
$15.7M Sell
111,349
-2,263
-2% -$330K 2.74% 8
2020
Q1
$14.9M Buy
113,612
+17,590
+18% +$2.5M 2.84% 5
2019
Q4
$14M Sell
96,022
-4,978
-5% -$675K 2.26% 6
2019
Q3
$13.1M Buy
101,000
+8,302
+9% +$1.09M 2.1% 7
2019
Q2
$12.9M Buy
92,698
+4,259
+5% +$590K 2.21% 6
2019
Q1
$12.4M Buy
88,439
+6,350
+8% +$851K 2.39% 6
2018
Q4
$10.6M Buy
82,089
+4,677
+6% +$652K 2.47% 5
2018
Q3
$10.7M Buy
77,412
+828
+1% +$110K 2.36% 6
2018
Q2
$9.29M Buy
76,584
+2,463
+3% +$307K 2.17% 7
2018
Q1
$9.5M Buy
74,121
+10,102
+16% +$1.37M 2.34% 7
2017
Q4
$8.95M Buy
64,019
+2,325
+4% +$324K 2.37% 6
2017
Q3
$8.02M Buy
61,694
+257
+0.4% +$34.1K 2.34% 7
2017
Q2
$8.13M Buy
61,437
+311
+0.5% +$39.7K 2.58% 7
2017
Q1
$7.61M Buy
61,126
+5,441
+10% +$650K 2.6% 8
2016
Q4
$6.42M Buy
55,685
+6,451
+13% +$745K 2.74% 6
2016
Q3
$5.82M Buy
49,234
+1,565
+3% +$190K 3.23% 6
2016
Q2
$5.78M Buy
47,669
+31,925
+203% +$3.63M 3.53% 4
2016
Q1
$1.7M Buy
15,744
+4,155
+36% +$430K 1.74% 13
2015
Q4
$1.19M Buy
+11,589
New +$1.17M 1.34% 13

Other funds holding JNJ

CWA Asset Management Group's JNJ Position: Q2 2026 in Review

CWA Asset Management Group increased its Johnson & Johnson (JNJ) stake by 0.87% in Q2 2026, buying an estimated $196K and bringing the position to 97,695 shares worth $24.8M. The position accounts for 0.76% of the portfolio, ranked #23.

CWA Asset Management Group first reported a position in JNJ in Q4 2015 and has held it in 42 quarters since. The position peaked at $32.2M in Q4 2022. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • CWA Asset Management Group held 97,695 shares of Johnson & Johnson worth $24.8M as of Q2 2026.
  • CWA Asset Management Group bought 841 Johnson & Johnson shares in Q2 2026, an estimated $196K.
  • Johnson & Johnson made up 0.76% of CWA Asset Management Group's portfolio in Q2 2026, its #23 holding.
  • CWA Asset Management Group first reported a position in Johnson & Johnson in Q4 2015 and has held it in 42 quarters since.
  • CWA Asset Management Group's Johnson & Johnson position peaked at $32.2M in Q4 2022.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.